Cartalax – Cartilage & Longevity Peptide
Cartalax is an advanced cartilage-targeting bioregulator peptide that promotes chondrocyte renewal and collagen-matrix integrity. Its short amino-acid sequences penetrate articular tissue to restore the gene expression patterns essential for flexible, resilient joints.
Description
Cartalax is a precision-engineered bioregulator peptide that selectively targets cartilage tissue through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within cartilage tissue cells, Cartalax helps normalise chondrocyte regeneration and collagen-matrix synthesis—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for musculoskeletal tissue maintenance, making it a fundamentally different approach from conventional supplementation.